Single-dose fluconazole versus itraconazole in pityriasis versicolor

Dermatology

Volumn 208, Issue 1, 2004, Pages 55-59

  Partap, R ^a   Kaur, I ^a   Chakrabarti, A ^a   Kumar, B ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Fluconazole, single dose; Itraconazole, single dose; Pityriasis versicolor

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; POTASSIUM HYDROXIDE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FUNGUS CULTURE; HUMAN; MALASSEZIA FURFUR; MALE; MYCOLOGY; PRIORITY JOURNAL; RELAPSE; SINGLE DRUG DOSE; TINEA VERSICOLOR;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTIFUNGAL AGENTS; FEMALE; FLUCONAZOLE; HUMANS; ITRACONAZOLE; MALE; MIDDLE AGED; TINEA VERSICOLOR; TREATMENT OUTCOME;

EID: 0942268180     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000075047     Document Type: Article

References (16)

1. Hickman JG: A double blind, randomized, placebo controlled evaluation of short-term treatment with oral itraconazole in patients with tinea versicolor. J Am Acad Dermatol 1996;34:785-787.
2. Delescluse J, Cauwenbergh G, Degreef H: Itraconazole, a new orally active antifungal in the treatment of pityriasis versicolor. Br J Dermatol 1986;114:701-703.
3. Kose O: Fluconazole versus itraconazole in the treatment of tinea versicolor. Int J Dermatol 1995;34:498-499.
4. Faergemann J: Treatment of pityriasis versicolor with a single dose of fluconazole. Acta Derm Venereol (Stockh) 1992;72:74.
5. Rao SVI, Rajashekhar N: Oral fluconazole in tinea versicolor. Ind J Dermatol Venereol Leprol 1997;63:166-167.
6. Cauwenbergh G, Degreef H, Haykants J, Woestenbergh R, Van Rooy P, Haeverans K: Pharmacokinetics profile of orally administered itraconazole in human skin. J Am Acad Dermatol 1988;18:263-268.
7. Midgley G: The diversity of Pityrosporum (Malassezia) yeasts in vivo and in vitro. Mycopathologica 1989;106:143-153.
8. Crespo EV, Ojeda MA, Vera CA, Crespo EA, Sanchez FF:Malassezia globosa as the causative agent of pityriasis versicolor. Br J Dermatol 2000;143:799-803.
9. Faergemann J, Fredriksson T: Tinea versicolor, some new aspects in etiology, pathogenesis and treatment. Int J Dermatol 1982;21:8-11.
10. De Doncker P, Gupta AK, Marynissen G, Stoffels P, Heremans A: Itraconazole pulse therapy for onychomycosis and dermatomycoses: An overview. J Am Acad Dermatol 1997;37:969-974.
11. Del Palacio Hernanz A, Delgado Vicente S, Menendez Ramos F, Rodriguez-Noriega Belaustegui A: Randomized comparative clinical trial of itraconazole and selenium sulfide shampoo for the treatment of pityriasis versicolor. Rev Infect Dis 1987;9(suppl 1):121-127.
12. Del Palacio Hernanz A, Frias-Iniesta J, Gonzalez-Valle O, Borgers M, Van Cutsem J, Cauwenbergh G: Itraconazole therapy in pityriasis versicolor. Br J Dermatol 1986;115:217-225.
13. Istroda RA: Itraconazole in pityriasis versicolor. Rev Infect Dis 1987;9(suppl 1):S128-S130.
14. Doria MM: Pityriasis versicolor: Efficacy of two five day regimens of itraconazole. Rev Infect Dis 1987;9(suppl 1):5131-5135.
15. Tucker RM, Haq Y, Denning DW: Adverse events associate with itraconazole in 189 patients on chronic therapy. J Antimicrob Chemother 1990;26:561-566.
16. Montero-Gei F, Robles EM, Suchil P: Fluconazole vs itraconazole in the treatment of tinea versicolor. Int J Dermatol 1999;38:601-603.